SarilumabMeSH Supplementary Concept

https://ansm.sante.fr/tableau-marr/sarilumab
2024
false
false
false
France
French
risk management
continuity of patient care
drug information
injections, subcutaneous
antibodies, monoclonal, humanized
sarilumab
patients guideline

---
https://www.has-sante.fr/jcms/p_3498124/fr/kevzara-sarilumab-polyarthrite-rhumatoide
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
sarilumab
drug therapy, combination
methotrexate
adult
injections, subcutaneous
evaluation of the transparency committee
arthritis, rheumatoid
sarilumab

---
https://www.has-sante.fr/jcms/p_3539144/fr/kevzara-sarilumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
injections, subcutaneous
sarilumab
biological therapy

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/COVID-19/Outil_clinique_Usage-Tocilizumab-Sarilumab.pdf
2021
false
false
true
Canada
French
Interleukin-6
quebec
tocilizumab
tocilizumab
sarilumab
sarilumab
treatment outcome
drug therapy, combination
glucocorticoids
adult
aged
Interleukin 6 receptor antagonist (disposition)
guidelines for drug use
receptors, interleukin-6
biological therapy
pneumonia, viral
coronavirus infections
antibodies, monoclonal, humanized
pandemics
COVID-19

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/COVID-19/COVID-19_INESSS_biotherapie_IL-1.pdf
2020
false
false
true
Canada
pneumonia, viral
coronavirus infections
Interleukin-6
quebec
siltuximab
siltuximab
tocilizumab
tocilizumab
sarilumab
sarilumab
treatment outcome
guideline
receptors, interleukin-6
biological therapy
interleukin-6
pneumonia, viral
coronavirus infections
pandemics
antibodies, monoclonal
antibodies, monoclonal, humanized
COVID-19

---
https://www.has-sante.fr/portail/jcms/c_2810337/fr/kevzara
https://www.has-sante.fr/portail/jcms/c_2810337/fr/kevzara-sarilumab-inhibiteur-des-recepteurs-de-l-interleukine-6
2017
false
false
false
France
French
antibodies, monoclonal, humanized
sarilumab
treatment outcome
sarilumab
adult
arthritis, rheumatoid
drug therapy, combination
methotrexate
injections, subcutaneous
Prefilled Syringe Dosage Form
Pre-filled Pen Syringe
interleukin-6 receptor alpha subunit
aged
evaluation of the transparency committee
comparative effectiveness research
insurance, health, reimbursement
guidelines for drug use
interleukin-6 receptor alpha subunit
sarilumab
antibodies, monoclonal, humanized

---
https://www.ema.europa.eu/medicines/human/EPAR/Kevzara
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
antibodies, monoclonal, humanized
sarilumab
drug approval
europe
treatment outcome
sarilumab
adult
arthritis, rheumatoid
drug therapy, combination
methotrexate
injections, subcutaneous
Prefilled Syringe Dosage Form
Pre-filled Pen Syringe
interleukin-6 receptor alpha subunit
interleukin-6 receptor alpha subunit
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
sarilumab
antibodies, monoclonal, humanized

---